Sonnet Biotherapeutics Stock Predictions

You'll find the sonnet biotherapeutics holdings share forecasts, stock quote and buy / sell signals below.according to present data sonnet biotherapeutics holdings's sonn shares and. Sonn | complete sonnet biotherapeutics holdings inc.

Sonnet Biotherapeutics Holdings Inc Price Sonn Forecast With Price Charts

The sonnet biotherapeutics holdings inc.

Sonnet biotherapeutics stock predictions. Powering a new wave of immune therapeutics. Sonnet biotherapeutics holdings inc (nasdaq: Sonn stock forecast our latest prediction for sonnet biotherapeutics holdings inc's stock price was made on the june 9, 2021 when the stock price was at 1.53$.

Sonnet biotherapeutics saw a decrease in short interest in october. Sonnet biotherapeutics stock price prediction is an act of determining the future value of sonnet biotherapeutics shares using few different conventional methods such as eps estimation, analyst consensus, or fundamental intrinsic valuation.the successful prediction of sonnet biotherapeutics' future price could yield a significant profit. This price target is based on 1 analysts offering 12 month price targets for sonnet biotherapeutics in the last 3 months.

Stock was originally listed at a price of $3,250.00 in oct 31, 2006. The consensus rating score for sonnet biotherapeutics is 3.00 while the average consensus rating score for medical companies is 2.73. This chart shows the closing price.

During the day the stock fluctuated 9.97% from a day low at $0.62 to a day high of $0.69. This is 9.09% more than the trading day before tuesday, 16th nov 2021. Wall street stock market & finance report, prediction for the future:

(nasdaq:sonn) shares, rose in value on thursday, september 23, with the stock price up by 3.99% to the previous day’s close as strong demand from buyers drove the stock to $0.62. On how sonn compares to other companies. Sonnet biotherapeutics holdings's share price could stay at $6.50 by sep 15, 2022.

Sonnet biotherapeutics holdings inc stock price forecast, sonn predictons for2021 As of october 29th, there was short interest totaling 488,700 shares, a decrease of 17.8% from the october 14th total of 594,200 shares. The sonnet biotherapeutics holdings inc.

On average, wall street analysts predict that. 31 2021, published 12:59 p.m. Buy or sell sonnet biotherapeutics holdings stock?

The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. Analysts like sonnet biotherapeutics stock more than the stock of other medical companies. Sonnet stock analysis notes the company had not issued any dividends in recent years.

During the day the stock fluctuated 8.98% from a day low at $0.60 to a day high of $0.65. Actively observing the price movement in the last trading, the stock closed the se As of 2021 november 15, monday current price of sonn stock is 0.626$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).

Sonnet biotherapeutics holdings stock price has been showing a declining tendency so we believe that similar market segments. Close price at the end of the last trading day (wednesday, 17th nov 2021) of the sonn stock was $0.65. Close price at the end of the last trading day (thursday, 18th nov 2021) of the sonn stock was $0.63.

The average sonnet biotherapeutics holdings stock price prediction forecasts a potential downside of n/a from the current sonn share price of $0.61. This is 3.1% less than the trading day before wednesday, 17th nov 2021. Sonnet biotherapeutics holdings inc () stock market info recommendations:

The company has developed fhab (fully human albumin binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory,. There are few to no technical positive signals at the moment. About the sonnet biotherapeutics holdings, inc.

At sonnet biotherapeutics, we are taking the fight directly to cancer.

Sonnet Biotherapeutics Holdings Inc Shares Close The Day 114 Higher - Daily Wrap Nasdaq